ARTICLE | Company News
Trimel Pharmaceuticals, Endo deal
December 15, 2014 8:00 AM UTC
Trimel granted Endo exclusive rights to commercialize Natesto in the U.S. and Mexico. FDA approved the bioadhesive intranasal gel formulation of testosterone in May to treat testosterone deficiency. ...